We studied tumour specimens from 106 patients with primary breast rumo
urs seen at the University Hospital of Patras, Greece, with a follow-u
p period of 3-10 years, focusing on the role of breast cancer angiogen
esis as a prognostic factor. Angiogenesis was assessed in the primary
tumour using an immunohistochemical stain for the CD31 antigen assay f
or quantitation of microvessel counts. Multiple regression analysis us
ing microvessel count and other clinical-histological findings (age, t
umour size, grade and lymphnode metastases) showed that only microvess
el counts were significantly predictive of haematogenous metastases to
lung, bones, liver and brain (chi(2) test, P = 0.022). This study sho
ws that angiogenesis is significantly predictive of haematogenous meta
stases.